IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $2.05, $0.13 better than the analyst estimate of $1.92. Revenue for the quarter came in at $829 million versus the consensus estimate of $820.91 million.

GUIDANCE:

IDEXX Labs sees FY2023 EPS of $9.27-$9.75, versus the consensus of $9.51. IDEXX Labs sees FY2023 revenue of $3.590-3.690 billion, versus the consensus of $3.619 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.